Invention Grant
- Patent Title: Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
- Patent Title (中): 静脉注射用乙酰水杨酸和茶氨酸的水溶性共晶体
-
Application No.: US13967027Application Date: 2013-08-14
-
Publication No.: US08685948B2Publication Date: 2014-04-01
- Inventor: Harry G. Brittain , Philip Felice
- Applicant: Theaprin Pharmaceuticals Inc.
- Applicant Address: US NY Hauppauge
- Assignee: Theaprin Pharmaceuticals Inc.
- Current Assignee: Theaprin Pharmaceuticals Inc.
- Current Assignee Address: US NY Hauppauge
- Agency: Notaro, Michalos & Zaccaria P.C.
- Main IPC: A61K31/60
- IPC: A61K31/60 ; A61K31/12
Abstract:
A method of treating rheumatoid arthritis using a water-soluble cocrystal composition contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from an alpha variant of theanine or a beta variant of theanine or other form of theanine.
Public/Granted literature
- US20130345183A1 INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE Public/Granted day:2013-12-26
Information query
